1. Home
  2. ARCT vs PHOS Comparison

ARCT vs PHOS Comparison

Compare ARCT & PHOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcturus Therapeutics Holdings Inc.

ARCT

Arcturus Therapeutics Holdings Inc.

N/A

Current Price

$10.29

Market Cap

293.9M

Sector

Health Care

ML Signal

N/A

Logo First Phosphate Corp. American Depositary Shares

PHOS

First Phosphate Corp. American Depositary Shares

N/A

Current Price

$11.30

Market Cap

271.7M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ARCT
PHOS
Founded
2013
2006
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
293.9M
271.7M
IPO Year
2019
2010

Fundamental Metrics

Financial Performance
Metric
ARCT
PHOS
Price
$10.29
$11.30
Analyst Decision
Strong Buy
Analyst Count
13
0
Target Price
★ $23.80
N/A
AVG Volume (30 Days)
★ 636.5K
29.1K
Earning Date
11-05-2026
11-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 20.00
N/A
EPS
N/A
★ N/A
Revenue
★ $82,031,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$54.47
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$5.50
$10.97
52 Week High
$17.96
$21.30

Technical Indicators

Market Signals
Indicator
ARCT
PHOS
Relative Strength Index (RSI) 45.33 38.07
Support Level $6.53 $10.97
Resistance Level $12.44 $13.30
Average True Range (ATR) 1.07 1.05
MACD -0.02 0.02
Stochastic Oscillator 37.25 7.26

Price Performance

Historical Comparison
ARCT
PHOS

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

About PHOS First Phosphate Corp. American Depositary Shares

First Phosphate Corp owns and is developing igneous rock phosphate mineral properties in the Saguenay Region of Quebec for the production of phosphoric acid for the production of cathode active material for use in lithium iron phosphate (LPF) batteries for the electric vehicle industry.

Share on Social Networks: